Diabetes Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Diabetes stocks.

Diabetes Stocks Recent News

Date Stock Title
May 13 BMY One stock is dragging down the S&P 500's earnings growth
May 13 BMY BMS and Zai Lab’s Augtyro gains NMPA approval to treat NSCLC
May 13 BMY Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study
May 13 BMY These Stocks Are Moving the Most Today: GameStop, AMC, Arm, Squarespace, Tesla, Intel, Apple, Incyte, and More
May 13 DXCM Bull Market and Beyond: 2 Stocks Just Waiting to Soar
May 13 BMY BMS Opdivo and Yervoy combo misses primary endpoint in Phase III NSCLC trial
May 13 GUTS Fractyl Health Presents Clinical Update on Revita® German Real-World Registry for Patients With Advanced Type 2 Diabetes (T2D)
May 12 EHAB Insider Spends US$82k Buying More Shares In Enhabit
May 12 DXCM Investors Will Want DexCom's (NASDAQ:DXCM) Growth In ROCE To Persist
May 12 BMY Down but Not Out: 3 Stocks to Buy on a Post-Earnings Dip
May 11 EMBC Embecta Corp. (EMBC) Q2 2024 Earnings Call Transcript
May 11 EHAB Enhabit, Inc. (EHAB) Q1 2023 Earnings Call Transcript
May 11 LLY 1 No-Brainer Growth Stock to Buy and Hold
May 11 BMY Is Bristol Myers' Dividend in Danger?
May 11 LLY Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
May 10 BMY Bristol Myers' Opdivo fails in Phase 3 lung cancer study
May 10 BMY Bristol Myers Squibb Cancer-Treatment Trial Misses Endpoint
May 10 BMY Bristol Myers Squibb Provides Update on Phase 3 CheckMate -73L Trial
May 10 ESPR Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
May 10 EHAB Enhabit Inc (EHAB) Reports Mixed Q1 2024 Results: Challenges and Strategic Adjustments Highlighted
Diabetes

Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications. Acute complications can include diabetic ketoacidosis, hyperosmolar hyperglycemic state, or death. Serious long-term complications include cardiovascular disease, stroke, chronic kidney disease, foot ulcers, and damage to the eyes.Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. There are three main types of diabetes mellitus:
Type 1 DM results from the pancreas' failure to produce enough insulin due to loss of beta cells. This form was previously referred to as "insulin-dependent diabetes mellitus" (IDDM) or "juvenile diabetes". The cause is unknown.
Type 2 DM begins with insulin resistance, a condition in which cells fail to respond to insulin properly. As the disease progresses, a lack of insulin may also develop. This form was previously referred to as "non insulin-dependent diabetes mellitus" (NIDDM) or "adult-onset diabetes". The most common cause is a combination of excessive body weight and insufficient exercise.
Gestational diabetes is the third main form, and occurs when pregnant women without a previous history of diabetes develop high blood sugar levels.Prevention and treatment involve maintaining a healthy diet, regular physical exercise, a normal body weight, and avoiding use of tobacco. Control of blood pressure and maintaining proper foot care are important for people with the disease. Type 1 DM must be managed with insulin injections. Type 2 DM may be treated with medications with or without insulin. Insulin and some oral medications can cause low blood sugar. Weight loss surgery in those with obesity is sometimes an effective measure in those with type 2 DM. Gestational diabetes usually resolves after the birth of the baby.As of 2015, an estimated 415 million people had diabetes worldwide, with type 2 DM making up about 90% of the cases. This represents 8.3% of the adult population, with equal rates in both women and men. As of 2014, trends suggested the rate would continue to rise. Diabetes at least doubles a person's risk of early death. From 2012 to 2015, approximately 1.5 to 5.0 million deaths each year resulted from diabetes. The global economic cost of diabetes in 2014 was estimated to be US$612 billion. In the United States, diabetes cost $245 billion in 2012.

Browse All Tags